-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

653.O2.6 653. Multiple Myeloma: Prospective Therapeutic Trials: Relapsed and Refractory Myeloma Clinically Relevant Abstract

Symposia: Multiple Myeloma: Prospective Therapeutic Trials Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Antibody Therapy, adult, Bispecific Antibody Therapy, Clinical Research, Plasma Cell Disorders, Diseases, Therapies, Immunotherapy, Lymphoid Malignancies, Adverse Events, Study Population, Human
Monday, December 11, 2023: 4:30 PM-6:00 PM
Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Urvi A Shah, MD, Memorial Sloan Kettering Cancer Center and Hans Lee, MD, MD Anderson Cancer Center
Shah: Janssen: Consultancy, Other: Advisory Board, Research Funding; Bristol Myers Squibb: Consultancy, Other: Advisory Board, Research Funding; M and M Labs: Research Funding; Plantable: Research Funding; Sabinsa: Research Funding; C4 Therapeutics: Research Funding; Sanofi: Other: Advisory Board. Lee: Janssen: Consultancy, Research Funding; Amgen: Research Funding; Regeneron: Consultancy, Research Funding; Allogene Thereapeutics: Consultancy; Takeda Pharmaceuticals: Consultancy, Research Funding; Monte Rosa Therapeutics: Consultancy; Pfizer: Consultancy; Sanofi: Consultancy; GlaxoSmithKline: Consultancy, Research Funding; Genentech: Consultancy; Bristol Myers Squibb: Consultancy, Research Funding; Celgene: Consultancy; AbbVie: Consultancy.
Prospective therapeutic trials with novel agents and combinations in relapsed and refractory myeloma.
4:30 PM

Yang Song, MBBS1*, Jin Seok Kim, MD, PhD2*, CS Chim, MD, PhD, BMBS3*, Je-Jung Lee4*, Sung-Soo Yoon, MD, PhD5, Soo Chin Ng, FRCP6, Gin Gin Gan7*, Hiroshi Handa8, Wei-Ying Jen, MD, FRCPath, MA1*, Xinhua Li9*, Yogesh Mahadev Pokharkar9*, Brian GM Durie, MD10 and Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP1

1Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
2Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of (South)
3Comprehensive Oncology Centre, 3/F, Li Shu Fan Block, Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong, China
4Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
5Department of Hemato-Oncology, Seoul National University Hospital, Seoul, Korea, Republic of (South)
6Subang Jaya Medical Center, Petaling Jaya, Malaysia
7University of Malaya, Kuala Lumpur, Malaysia
8Department of Hematology, Gunma University Hospital, Maebashi, Gunma, Japan
9Singapore Clinical Research Institute, Singapore, Singapore
10Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA

4:45 PM

Ajai Chari, MD1*, Albert Oriol, MD2*, Amrita Krishnan, MD3, Maria Del Carmen Martinez Chamorro4*, Luciano Costa, MD, PhD5, Maria Victoria Mateos, MD, PhD6, Monique C Minnema7*, Michela Campagna, PhD8*, Tara J Masterson, MS9*, Brandi W Hilder, PhD9, Jaszianne Tolbert, MD10, Thomas Renaud, MD10, M. Damiette Smit11*, Swarna Ramanjulu9* and Paula Rodríguez Otero12*

1at the time that the work was performed, Mount Sinai School of Medicine, New York, NY
2Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
3Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Irvine, CA
4University Hospital Quirónsalud, Pozuelo de Alarcón, Madrid, Spain
5University of Alabama at Birmingham, Birmingham, AL
6University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
7University Medical Center Utrecht, Utrecht, Netherlands
8Janssen Research & Development, Madrid, Spain
9Janssen Research & Development, Spring House, PA
10Janssen Research & Development, Raritan, NJ
11Janssen Biologics BV, Leiden, Netherlands
12Clínica Universidad de Navarra, Pamplona, Spain

5:00 PM

Hang Quach, MD, FRACP, FRCPA, MBBS1, Doug Sborov2, Dickran Kazandjian, MD3, Andrew Spencer, MBBS, MD, FRACP, FRCPA4*, Michael Low5*, Susan Bal, MD6, Natalie S. Callander, MD7, Huan Cheng8*, Sheel Patel8*, Rocco J. Crescenzo, DO8*, Amit Agarwal9* and Binod Dhakal, MBBS10

1St. Vincent's Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia
2University of Utah School of Medicine, Salt Lake City, UT
3University of Miami, Coral Gables, FL
4Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia
5Monash Haematology, Monash University, Clayton University, Victoria, Australia
6University of Alabama at Birmingham, Birmingham, AL
7UW Health University Hospital, Madison, WI
8BeiGene USA, Inc, San Mateo, CA
9BeiGene, San Mateo, CA
10Medical College of Wisconsin, Milwaukee, WI

5:15 PM

Sumit Madan, MD1, Caitlin L. Costello, MD2, Brea Lipe, MD3, Andrew J. Cowan, MD4,5,6,7,8,9, Eva Medvedova, MD10*, Jens Hillengass, MD, PhD11, P. Leif Bergsagel, MD12, Xavier Leleu, MD13, Cyrille Touzeau, MD, PhD14*, Daniel Morillo, MD15*, Albert Oriol16*, Raya Mawad, MD17, Henning Schade, MD18*, Salomon Manier, MD, PhD19, Yifah Yaron, MD, PhD20*, Banmeet Anand, PhD20* and Al-Ola Abdallah, MD21

1Banner MD Anderson Cancer Center, Gilbert, AZ
2Moores Cancer Center at University of California San Diego, San Diego, CA
3University of Rochester Medical Center, Rochester, NY
4Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
6Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
7University of Washington/Fred Hutchinson Cancer Center, Seattle, WA
8University of Washington, Seattle, WA
9Division of Medical Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA
10Knight Cancer Institute, Oregon Health & Science University, Portland, OR
11Roswell Park, Buffalo, NY
12Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ
13Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France
14Centre Hospitalier Universitaire de Nantes, Nantes, France
15Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
16Hematology Department, Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain
17Fred Hutchinson Cancer Center, Seattle, WA
18Colorado Blood Cancer Institute, Denver, CO
19CHU Lille, Université de Lille, Lille, France
20Harpoon Therapeutics, South San Francisco, CA
21University of Kansas Medical Center, Kansas City, KS

5:30 PM

Paul G. Richardson, MD1, Irwindeep Sandhu2, Craig C. Hofmeister, MD3, Robert Z. Orlowski, MD, PhD4, Darrell White5, Angelo Belotti, MD6*, Charlotte Toftmann Hansen7*, Noopur S. Raje8*, Tracy T. Chow9*, Zehua Zhou9*, Tiziana Civardi10*, Phillip Koo9*, Yue Zhu9*, Jessica Katz9 and Albert Oriol11*

1Dana-Farber Cancer Institute, Boston, MA
2Cross Cancer Institute, Edmonton, AB, Canada
3Winship Cancer Institute of Emory University, Atlanta
4Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
6Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
7Odense University Hospital, Odense, Denmark
8Massachusetts General Hospital, Boston, MA
9Bristol Myers Squibb, Princeton, NJ
10Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
11Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain

5:45 PM

Jeffrey V Matous, MD1, Noa Biran, MD2, Aurore Perrot, MD, PhD3, Jésus G Berdeja, MD4, Kathleen Dorritie, MD5, Janine Van Elssen, MD, PhD6*, Emma Searle, MD7*, Cyrille Touzeau, MD, PhD8*, Sébastien Anguille9*, Deeksha Vishwamitra, PhD10, Ashley Nguyen10*, Debopriya Ghosh11*, Elizabeth Shearin, PharmD12*, Katherine Thornton10*, Damiette Smit13* and Hang Quach, MD, FRACP, FRCPA, MBBS14

1Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
2Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
3Service Hematologie, CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
4Sarah Cannon Research Institute, Nashville, TN
5UPMC Hillman Cancer Center, Pittsburgh, PA
6Maastricht University Medical Center, Maastricht, Netherlands
7The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
8Centre Hospitalier Universitaire de Nantes, Nantes, France
9Antwerp University Hospital, Edegem, Belgium
10Janssen Research & Development, Spring House, PA
11Janssen Research & Development, Bridgewater, NJ
12Janssen Research and Development, Spring House, PA
13Janssen Biologics Europe, Leiden, Netherlands
14St. Vincent's Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia

*signifies non-member of ASH